Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Argan (AGX) Liabilities and Shareholders Equity: 2009-2025

Historic Liabilities and Shareholders Equity for Argan (AGX) over the last 17 years, with Oct 2025 value amounting to $1.1 billion.

  • Argan's Liabilities and Shareholders Equity rose 36.68% to $1.1 billion in Q4 2025 from the same period last year, while for Oct 2025 it was $3.6 billion, marking a year-over-year increase of 31.05%. This contributed to the annual value of $836.2 million for FY2025, which is 39.78% up from last year.
  • Per Argan's latest filing, its Liabilities and Shareholders Equity stood at $1.1 billion for Q4 2025, which was up 19.05% from $882.7 million recorded in Q3 2025.
  • Argan's Liabilities and Shareholders Equity's 5-year high stood at $1.1 billion during Q4 2025, with a 5-year trough of $410.9 million in Q4 2022.
  • Its 3-year average for Liabilities and Shareholders Equity is $692.9 million, with a median of $675.5 million in 2024.
  • As far as peak fluctuations go, Argan's Liabilities and Shareholders Equity crashed by 35.11% in 2022, and later soared by 43.67% in 2024.
  • Argan's Liabilities and Shareholders Equity (Quarterly) stood at $613.2 million in 2021, then slumped by 32.99% to $410.9 million in 2022, then spiked by 37.17% to $563.7 million in 2023, then skyrocketed by 36.41% to $768.9 million in 2024, then skyrocketed by 36.68% to $1.1 billion in 2025.
  • Its Liabilities and Shareholders Equity stands at $1.1 billion for Q4 2025, versus $882.7 million for Q3 2025 and $792.2 million for Q2 2025.